February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
David J. Benjamin: Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?
Jan 26, 2025, 21:58

David J. Benjamin: Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?

David J. Benjamin, Medical Oncologist at the Hoag Family Cancer Institute, sharted a recent article by him and colleagues on X:

“Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?

In European Urology Oncology, we discuss the potential roles of G-CSF, dosing approaches, and differences in patient population compared to the TROPHY-U-01 trial.”

Implications and Lessons from the Withdrawal of Sacituzumab Govitecan for Treating Advanced Urothelial Carcinoma

Authors: David J. Benjamin, Arash Rezazadeh Kalebasty, and Nataliya Mar

David J. Benjamin

More posts featuring David J. Benjamin.